Dr.J. Jebasingh Medical Oncologist in Madurai

Dr.J. Jebasingh
Medical Oncologist, Madurai

MBBS, MD, DM

  • 2 Hospitals
  • Dr.J. Jebasingh is a Consultant at Asirvatham Speciality Hospital, Hannah Joseph Hospital, Madurai

Specialities

  • Medical Oncology

Expertise


Education

MBBS, 1993, Christian Medical College, Vellore

MD (Radiotherapy), 1999, Madurai Medical College, Madurai

DNB (Gen Medicine), 2000, Meenakshi Mission Hospital & Research Centre, Madurai

Practice Information

Asirvatham Speciality Hospital, Madurai

Asirvatham Speciality Hospital, Madurai

22, Rajaji Street, Near Anna Bus Stand, Gandhi Nagar, Madurai, Tamil Nadu - 625020

MON, TUE, WED, THU, FRI, SAT

02:30 PM - 07:30 PM

Hannah Joseph Hospital, Madurai

Hannah Joseph Hospital, Madurai

134, Lake View Road, Managiri, Madurai, Tamil Nadu - 625020

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr.J. Jebasingh and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • COX-2 inhibitor with concurrent chemoradiotherapy in head and neck cancers. European Journal of Cancer. Supplements; 2007.
  • Catalase activity in oesophageal cancer. International Journal of Scientific Research. May 2013.
  • Pathology of Brain Tumors. State Conference of Association of Radiation Oncologists of India. Madurai, 1997.
  • Paper Presentation: Analysis of Nasopharyngeal Cancers. State Conference of Association of Radiation Oncologists of India. Chennai, 1998. [Best Paper Award]
  • Several presentations made at Clinical Society and Physician's Conference during DM (Oncology) course at Chennai.
  • Many cases presented at monthly city hemato-oncology meets in Chennai between 2003 and 2006.
  • Paper Presentation: COX2 inhibitors with concurrent chemo-radiation in head and neck cancers. ECCO-14. European Cancer Congress. Barcelona.
  • Paper Accepted: Pattern of return to workplace in breast cancer survivors. ESGO-2007. European Society of Gynecological Oncology. Berlin, 2007.
  • Paper Accepted: Curcumin a NF-kB inhibitor with concurrent chemo-radiation in locally advanced head and neck cancers. UICC 2008. International Union Against Cancer. Geneva, 2008.
  • Lecture delivered: Newer Techniques in Radiation Oncology. IMA-Erode. 2001.
  • Member, ESMO (European Society of Medical Oncology)
  • Member, ICON (Indian Co-operative Oncology Network)
  • Member, IGCS (International Gynecological Cancer Society)
  • Member, AGOI (Association of Gynecological Oncologists in India)